Top Medical News

NeurologyLive® Top Expert Interviews: June 2022

July 07, 2022

By Matt Hoffman

Expert clinicians offer their insight on the sleep disorder landscape, the state of mental health in pediatric migraine, an inaugural movement disorders congress, a novel stroke rehabilitation tool, and psychedelics in cluster headache.

FDA Accepts BLA for Lecanemab in Alzheimer Disease, Sets PDUFA Date for January 2023

July 07, 2022

By Marco Meglio

In addition to filing under the accelerated approval pathway, Eisai will submit for a traditional approval of lecenamab before the end of the first quarter of 2023, seeking an indication for mild cognitive impairment because of Alzheimer disease.

FDA Advisory Committee Agrees to Reconvene for Decision on ALS Treatment AMX0035

July 06, 2022

By Marco Meglio

In the original panel discussion, held in March 2022, the majority of members of the committee voted that AMX0035 did not fully demonstrate sufficient efficacy as a treatment for ALS.

NeuroVoices: Francois Bethoux, MD, on Innovating MS Rehabilitation With the EksoNR Exoskeleton

July 06, 2022

By Marco Meglio

The chair of Cleveland Clinic’s Department of Physical Medicine discussed a new rehabilitative approach using a robotic exoskeleton to improve fatigue and gait in patients with multiple sclerosis.

Presence of MOG-IgG in Children Meeting MS Criteria May Allude to Nontypical Disease Course

July 05, 2022

By Marco Meglio

All 12 of the children met diagnostic criteria for multiple sclerosis and were seropositive for MOG-IgG at baseline experienced a disease course different than typical MS through the observed time.

Featured


Latest Videos


Most Recent